Fuse Medical’s (OTC: FZMD) recent purchase of Maxim Surgical was an all-stock transaction worth $3,276,488, according to a recent Securities and Exchange Commission (SEC) filing.
Maxim is a spinal fusion device company and device distributor. Closed on Aug. 1, the Maxim deal was the second acquisition in the past year for Fuse, which purchased CPM Medical Consultants in December 2017. All three companies are based in Richardson, Texas.
Fuse issued 4,311,169 restricted shares of its common stock to Maxim at an agreed-upon value of $0.76 per share, which was equal to the 30-day volume-weighted average price of the Fuse’s common stock as of three business days prior to the closing, according to the SEC filing.
Get the full story on our sister site, Medical Design & Outsourcing.
The post Fuse + Maxim = an all-stock transaction appeared first on MassDevice.
from MassDevice https://ift.tt/2PrYIN1
Cap comentari:
Publica un comentari a l'entrada